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Abstract: Ex situ machine perfusion is a promising technology to help improve organ viability prior
to transplantation. However, preclinical studies using discarded human livers to evaluate therapeutic
interventions and optimize perfusion conditions are limited by significant graft heterogeneity. In
order to improve the efficacy and reproducibility of future studies, a split-liver perfusion model
was developed to allow simultaneous perfusion of left and right lobes, allowing one lobe to serve
as a control for the other. Eleven discarded livers were surgically split, and both lobes perfused
simultaneously on separate perfusion devices for 3 h at subnormothermic temperatures. Lobar
perfusion parameters were also compared with whole livers undergoing perfusion. Similar to
whole-liver perfusions, each lobe in the split-liver model exhibited a progressive decrease in arterial
resistance and lactate levels throughout perfusion, which were not significantly different between
right and left lobes. Split liver lobes also demonstrated comparable energy charge ratios. Ex situ
split-liver perfusion is a novel experimental model that allows each graft to act as its own control.
This model is particularly well suited for preclinical studies by avoiding the need for large numbers
of enrolled livers necessary due to the heterogenous nature of discarded human liver research.
Keywords: machine perfusion; liver transplant; liver perfusion; split liver; ex situ perfusion;
subnormothermic; normothermic; energy charge
1. Introduction
The number of liver transplants performed annually has increased substantially in recent years,
and yet 20% of listed patients die before an organ becomes available [1]. Currently, up to 30%
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of deceased donor livers are recovered but not transplanted [2], representing a significant pool of
potentially viable grafts. In a recent randomized controlled trial, normothermic machine perfusion has
been demonstrated to decrease discard rates without sacrificing recipient outcomes [3]. These findings
were especially pronounced in donation after cardiac death (DCD) grafts, providing further evidence
for the potential role of machine perfusion (MP) to resuscitate and subsequently improve utilization of
marginal or currently discarded livers [4–13].
Despite strong evidence demonstrating the benefit of MP for graft resuscitation and assessment,
there continues to be a significant number of grafts that are either not procured due to perceived donor
risk factors, or still discarded after machine perfusion due to poor function. In order to further alleviate
the organ shortage, it will be necessary to leverage the potential of MP to rehabilitate grafts that would
traditionally be discarded [14]. However, traditional perfusion research studies designed to test a
novel therapeutic in discarded human livers are hindered by the significant heterogeneity of discarded
grafts. As a result, adequate power and sample size are extremely difficult to obtain.
We therefore developed an experimental split-liver MP technique, in which a whole liver is
anatomically split into left and right lobes during back bench preparation and the two lobes are
perfused concurrently on separate perfusion devices. We hypothesized that individual lobes would
recover during MP similarly to whole-liver perfusion, and that individual lobes from the same liver
would perform similarly to one another. The novelty of this technique is that each perfusion experiment
has an internal control and does not rely on matching with historical controls.
2. Materials & Methods
2.1. Donor Liver Selection
Livers declined for transplantation from donors with consent for research were obtained through
New England Donor Services (NEDS). Livers with evidence of cirrhosis, major lacerations, or anatomic
variations that preclude adequate perfusion after splitting were excluded. Table 1 describes the donor
characteristics of the grafts that were included in this study. This study was approved by NEDS and
the Massachusetts General Hospital institutional review board (Protocol # 2011P001496). No organs
were procured from prisoners, and no vulnerable populations were included in this study.
Table 1. Demographic data of discarded livers undergoing SNMP.
Split-Liver Grafts (n = 11) Whole-Liver Grafts (n = 4)
Age (years) 51 (36–59) 49 (41–50)
Gender (male) 8 (73%) 4 (100%)
Body mass index (kg/m2) 28.9 (25–32.4) 28.2 (26.5–30.7)
DCD recovery 9 (82%) 4 (100%)
Reasons for declining livers for
transplantation
 DCD + Age >55 years + macrosteatosis > 30%
 DCD + macrosteatosis >30% (×2)
 DCD + Age >55 years (×4)
 Atherosclerosis
 Lack of serology information
 Poor back table flush
 Unknown
 Warm ischemia > 30 min
 DCD + Age > 55 years
Warm ischemia (min) 31 (24–37) 26 (24–30)
Cold ischemia (min) Right lobe: 697 (611–760)Left lobe: 669 (543–708) 724 (694–788)
Weight of liver (g) Right lobe: 1027 (893–1329)Left lobe: 553 (499–677) 2139 (1892–2376)
Donor risk index 2.14 (1.55–2.37) 2.06 (1.73–2.47)
Continuous variables are presented as median with interquartile range (IQR). Categorical variables are presented
as number and percentage. Abbreviations: DCD, Donated after circulatory death; SNMP, subnormothermic
machine perfusion.
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2.2. Donor Liver Procurement
Each liver was procured in standard fashion utilizing University of Wisconsin (UW) solution
(Bridge to Life Ltd., Columbia, SC, USA) for cold flush and preservation. For DCD grafts, total warm
ischemia time (WIT) was defined as the time from withdrawal of life support to in situ cold flush. All
grafts were subsequently transported to the laboratory under standard static cold storage conditions.
2.3. Split-Liver Technique
After arrival, the donor liver was placed in fresh, ice-cold UW solution on the back table, and an
anatomic split into right and left lobes was performed. Briefly, the portal vein (PV), hepatic artery
(HA), and common bile duct (BD) were dissected to the level of their bifurcations, using caution to
identify and preserve any replaced or accessory arteries (Figure 1A). Crossing arteries to segment 4
were identified and kept in continuity with the right hepatic artery. The cystic duct was ligated, and
cholecystectomy performed. The space between the right and middle hepatic veins was identified by
removing excess diaphragmatic tissue and suprahepatic vena cava. The inflow vessels to each lobe
and the draining bile ducts from each lobe were identified and marked with silk ties. The liver was
then sharply divided through Cantlie’s line (Figure 1B). Our perfusion system has open caval drainage
collection, rather than being collected through an indwelling catheter connected to the circuit, so the
integrity of the hepatic veins was not necessary to maintain venous drainage. The line of dissection
through the hilum coursed between the previously marked vessels to maintain the branches with
their respective lobes. After parenchymal dissection, the vessels and bile ducts were divided at the
bifurcation. The main hepatic vessel/duct was maintained with one lobe, closing the defect where
the branch to the contralateral lobe had been divided with 6-0 polypropylene suture in a transverse
fashion to avoid narrowing the vessel or duct. The contralateral lobe received only the intact lobar
vessel/duct; the choice of which lobe received the lobar or the main vessel depended on which lobe
appeared to have a longer vessel for cannulation. If the lobar vessel was still too short to cannulate,
a graft was sewn on to allow to enough length for the cannula to be secured and not obstruct any
branches. In cases where the line of splitting would compromise caudate lobe inflow, this segment
was resected. The hepatic arteries of each lobe were cannulated with 10–12 F cannulas, and the portal
veins were similarly cannulated with 24 F cannulas (Organ Assist, Groningen, The Netherlands). To
collect bile, each lobe’s respective duct was cannulated with a 4 mm acorn tip cannula (Medtronic,
Minneapolis, MN, USA) (Figure 1C,D). The hepatic veins in both lobes were left open to allow free
drainage into the organ reservoir during perfusion. After cannulation, the cut surfaces of the liver
were sealed with Loctite medical grade adhesive (Henkel Corp., Rocky Hill, CT, USA) to prevent
excess bile leakage. Livers were split prior to placing on pump so that each lobe could be perfused
and analyzed independently on two different circuits. Split-liver perfusion data were also compared
with perfusion of four whole-liver graft prepared in the standard fashion. Split lobes and whole livers
were weighed immediately before and after perfusion. All functional data were normalized to the
preperfusion weight.
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Figure 1. Splitting of discarded donor liver. (A) The whole graft is thoroughly explored, and dissection
is performed to the level of the bifurcation of the hepatic artery (HA), portal vein (PV), and bile duct
(BD). (B) An anatomical split is performed, with assurance of adequate inflow and outflow. (C) The
right lobar and (D) left lobar HA, PV, and BD are cannulated.
2.4. Ex Situ Subnormothermic Machine Perfusion (SNMP)
Subnormothermic perfusion of each lobe was initiated utilizing a custom perfusion system as
described previously [15–17]. Of note, one liver (#8) was perfused using the Liver Assist device (Organ
Assist, Groningen, The Netherlands) rather than the custom system to further demonstrate feasibility
on a commercial device. The acellular perfusate consisted of Williams E medium (Sigma-Aldrich,
St. Louis, MO, USA), heparin (Heparin Sodium, Pfizer, New York City, NY, USA), hydrocorticosone
(Solu-Cortef, Pfizer, Ney York City, NY, USA), and insulin (Humulin R, Eli Lilly & Co., Indianapolis,
IN, USA) and was supplemented with 8.4% sodium bicarbonate as needed to maintain pH >7.2 [16,17].
The perfusate was oxygenated with a 95% O2/5% CO2 gas mixture to achieve a partial oxygen pressure
>700 mmHg. Temperature was maintained at 20–21 ◦C. Prior to initiating perfusion, each lobe was
flushed with 2 L of cold Lactated Ringer’s solution divided between the portal vein and hepatic artery
to clear the preservation solution. Preperfusion weights of each lobe were recorded. Perfusion of the
individual lobes was started in succession, typically within 10 min of each other, and each lobe was
perfused for a total duration of 3 h. Our previous work has shown that this duration is sufficient to
demonstrate lactate clearance, ATP replenishment, and bile production in whole-liver SNMP [16]. Flow
rates were adjusted to maintain portal vein pressures of 3–7 mmHg and hepatic arterial pressures of
40–60 mmHg. Vascular resistance was calculated as pressure (mmHg) divided by weight-adjusted flow
(mL/min/kg). Hemodynamic parameters were recorded at regular time intervals. Bile was collected
and quantified hourly.
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2.5. Biochemical Profiling
Perfusate samples were taken every 30 min for the first hour, then hourly thereafter for testing
of injury markers, electrolytes, and blood gas analysis. Electrolytes, glucose, lactate, and blood gas
analysis were performed utilizing an i-STAT Blood Analyzer (Abbott Point of Care Inc., Princeton, NJ,
USA). Alanine aminotransferase (ALT) levels were assayed utilizing an Infinity liquid stable reagent
(Thermo Fisher Scientific Inc., Middletown, VA, USA).
2.6. Evaluation of Hepatic Energy Charge
Wedge biopsies of the liver were taken hourly and flash frozen in liquid nitrogen. Biopsies
were taken in the periphery of each lobe, away from the vascular pedicle, and opposite the
cut edge of the split lobes to avoid injury to large vascular or biliary branches. These samples
were later pulverized and processed for mass spectrometry analysis utilizing previously described
protocols [18,19]. Metabolic cofactors (ATP, ADP, AMP) were analyzed with a LC-MS/MS (Sciex
TripleTOF 6600 Quadrupole Time-Of-Flight; AB Sciex, Foster City, CA, USA). Energy charge was
calculated as [ATP + ADP × 0.5]/[ATP + ADP + AMP].
2.7. Histological Evaluation
Biopsies of the liver parenchyma were fixed in formalin, embedded in paraffin, cut, and stained with
hematoxylin and eosin (H&E). A blinded pathologist (EOAH) evaluated the biopsies for preservation
injury and ischemic necrosis.
2.8. Statistical Analysis
Data was analyzed using Prism 7 (GraphPad Inc., La Jolla, CA, USA). Categorical variables are
presented as column percentages. Continuous variables are presented as the median with interquartile
ranges (IQR), except when specified. To ensure valid comparisons, values were normalized to lobar or
whole-liver weight. Group medians of continuous data were compared using the Mann–Whitney U
test at each time point. A p-value <0.05 was considered statistically significant.
3. Results
3.1. Donor Characteristics
Included in this study were 15 discarded human livers: 11 underwent split-lobar SNMP and
4 underwent whole-graft SNMP. The median donor age was 53 years (IQR 15–69), and nine grafts (82%)
were from DCD donors (Table 1). The median relative WIT was 33 min (IQD 20–48). As expected, right
lobes had significantly higher mass compared with left lobes (p = 0.0003). There were no significant
differences between the split and the whole livers in terms of cold ischemic time (CIT), WIT, or donor
risk index (DRI).
3.2. Perfusion Hemodynamics
Hepatic arterial resistance improved during perfusion in individual lobes. Portal resistance was
relatively consistent throughout perfusion in left and right lobes (Figure 2A,B). Right lobes tended
to have higher arterial and portal resistance compared with left lobes, though this did not reach
significance at any time point. During perfusion of split livers, patterns of vascular resistance were
analogous to those of whole-liver perfusions. However, in some of the individual livers, the HA and
PV resistances were different between the lobes, and in some of the livers, we were unable to measure
HA resistances (Supplemental Figures S1 and S2).
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Figure 2. Median vascular resistance of splits lobes during perfusion is statistically the same. (A) Hepatic
arterial resistance was qualitatively higher in the right lobes compared with the left lobes, though did
not reach statistical significance at any time point. Interestingly, whole-graft arterial resistance was
approximately the average of the individual lobes. (B) Split right lobes tended to have higher portal
venous resistance during perfusion compared with left lobes (not significant throughout), while whole
grafts had lower overall portal venous resistance than individual split lobes.
3.3. Injury and Functional Recovery
Comparisons of injury and functional mark owed similar recovery patte ns for both split-
and whole-liver perfusions. ALT levels tended to be higher in the left lobes, but levels remained
stable throughout perfusion in both lobes (Figure 3A). Whole grafts consistently had lower ALT
levels throughout perfusion compared with split lobes, reflecting the injury induced during splitting.
Individual split-lobe ALT patterns are demonstrated in Figure S3. Lactate levels after initiation of
perfusion were highest in the left lobe, though both l bes demonstrated l ctate clearance during
perfusion (no s gn ficant difference betwe lobes). Whole graft had lower lactat levels compared
with the individual lobes (Figure 3B). Even though the lactate levels were different between the right
and left lobe in some individual livers, the rate of decline remained similar among the lobes during the
perfusion of most livers (Figure S4). With respect to graft edema, left lobes gained a median 0.003 kg
(IQR, 0.026, 0.147) while right lobes gained a median 0.014 kg (IQR, 0.130, 0.190). Weight change was
not statistically significant when compared within and betw en lobes.
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Figure 3. Hepatocyte injury and functional recover similar between split lobes during perfusion.
(A) ALT (alanine aminotransferase) levels were comparable during perfusion between split right and
left lobes (no significant difference). Whole grafts had lower ALT levels throughout perfusion compared
with indi idual lobes, indicati e of the cellular injury induces during surgical splitting. (B). Lactate
levels tended to be higher in split left lobes but were not statistically significant from right lobes. Lactate
levels decreased slowly during perfusion in both lobes. Whole grafts had lower lactate levels compared
with individual lobes.
Another potential marker of hepatocyte function is bile production [20,21]. Bile is usually
produced at a rate of 2–3 mL/hour in whole livers during SNMP. In our early trials of split perfusion,
bile production was not present, but later, the two split lobes generated a total bile volume of about
one-third to one-half of the volume produced by a whole liver.
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3.4. Liver Energy Status
ATP generation during perfusion is a potential viability marker that may be predictive of allograft
function after transplantation [19,22]. Notably, the ATP:ADP and ATP:AMP ratios increased similarly
between split lobes and whole grafts within the first 2 h and decreased slightly by the third hour among
all groups (Figure 4A,B). The energy charge ratio followed a similar pattern among the three groups.
No significant differences were seen in comparison of left and right lobes for the energy ratios. The
individual changes in energy charge in each liver are demonstrated in Figure S5.
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3.5. Preservation Histology
Individual split lobes showed good preservation histologically at the end of perfusion. Ischemic
necrosis was observed in initial biopsies, and this finding either remained stable or slightly improved
in some liver . Within each liver, there were no notable differences in preserv tion injury, ischemic
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right or left lobes of each individual liver. CV, central vein. * indicates areas of sinusoidal congestion.
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4. Discussion
Ex situ MP is a promising tool to address current organ shortages, while also improving liver
transplantation outcomes [3,5,23]. Research models of liver machine perfusion in animals and discarded
human donor livers provide a platform to optimize MP protocols and develop therapeutic interventions
that can be used in clinical trials. However, research involving discarded human organs is often
criticized due to the significant heterogeneity between donors and the small sample sizes characteristic
of these studies, which render adequate comparisons difficult. As such, most conclusions drawn
are met with an understandable degree of skepticism and uncertainty regarding generalizability. To
address this issue and improve the quality and rigor of preclinical perfusion studies, we adapted
the clinical split-liver technique for deployment with ex situ MP in order to create a model that
would allow internal controls for each liver. Other groups have modeled split-lobe perfusion in
large animals [24], and a brief letter demonstrated the surgical feasibility of liver splitting during
normothermic perfusion [25]. Our technique builds on this work by incorporating two separate
perfusion circuits, providing a controlled comparison of perfusion and functional characteristics
between the split lobes. Utilizing this method, we found that single lobes behave similarly both to
each other and to whole livers during SNMP, and that splitting discarded livers does not significantly
impair the ability to perform MP. Moreover, we developed a protocol that enables performing the split
operation prior to the perfusion within a reasonable time period. The split-liver model is suitable for
preclinical research with human livers to compare the efficacy of different therapeutic interventions
during MP prior to initiation a clinical trial. When assessing treatment efficacy with this model, it may
be helpful to track differences between lobes of individual livers in addition to differences between the
experimental and control lobes in aggregate.
Of note, during our early experiments, we found that bile production was inconsistent in split
liver lobes. This could be attributable to the extra damage sustained during splitting and manipulation
of the liver before perfusion or difficulty cannulating the bile ducts. Bile production increased in
our later experiments, suggesting that our early difficulties were related to the surgical technique
that improved with experience. In these latter experiments, we observed total bile production to be
approximately one-third of the volume produced by whole-liver grafts (when normalized to weight),
potentially indicating bile leakage from the cut surface and that further improvements in technique
may be needed if bile production is of key interest.
There are a few notable limitations of the split-liver perfusion technique. The first is prolongation
of cold ischemia time during the split procedure. In our initial experiments, splitting the liver took up
to 2 h to complete. This compares to approximately 30 min for back bench preparation of a whole-liver
graft. With experience, we were able to complete the split in 45–60 min, a notable improvement which
is only minimally increased compared with the time required for preparation of a whole-liver graft.
Additionally, not all discarded livers are suitable to be split due to anatomic reasons, for instance, in
cases where there are multiple small arterial branches, or the arterial supply is not clearly defined.
The shorter, smaller-caliber branched vessels and ducts are certainly more difficult to cannulate than
the celiac axis or main portal vein in a whole-liver graft. Not unexpectedly, the arterial and portal
resistances often varied between the lobes in individual livers, and higher arterial resistances were
observed during the perfusion of split right lobes compared with left lobes and whole grafts. This
may have been due to the surgical adhesive applied to the cut surfaces of the split lobes, which did
lessen raw surface bleeding but could have artificially increased vascular resistance. Additionally, the
significant difference in lobar weights also contributed to the difference in weight-normalized vascular
resistance. This technique could be further refined in future studies by using a preset weight-based
flow goal for the arterial and portal circuits and adjusting perfusion pressures to achieve the flow goals.
In one study of whole-liver perfusions, Boteon et al. used 0.25 mL/min/g liver tissue and 0.75 mL/min/g
liver tissue for arterial and portal flow goals, respectively, at normothermic temperatures [26].
Similarly, we observed that individual lobes had higher lactate levels during perfusion compared
with whole-liver grafts, even though they maintained a similar rate of lactate clearance. It is worth
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mentioning that in individual livers, the slope of decrease in the lactate among the lobes was similar
in most of the livers. Interestingly, energy charge ratios were the most closely associated functional
parameter between lobes of the same liver, indicating the potential value of its use as a biomarker in
future studies.
We chose SNMP for this study rather than hypothermic or normothermic MP because SNMP
provides more functional information hypothermic MP, while avoiding the more costly need for
oxygen carriers required in normothermic MP. However, this model can easily be extended for detailed
studies under normothermic conditions. Multiple studies using animal or discarded human livers
without transplantation have demonstrated that SNMP improves liver viability and that perfusion
characteristics correlate with injury and predict post-transplant function [16–18,27–33]. As previously
noted, validating perfusion protocols or determining viability parameters was outside the scope of
this study. Therefore, we did not attempt to identify discarded livers that would be suitable for
transplantation. Rather, we focused on a clear set of injury and functional parameters that have been
well described in the literature to quantitatively demonstrate that individual lobes from one liver graft
are comparable during MP.
It is important to emphasize that the described technique is intended for use in preclinical studies
and would require significant modification if the goal of splitting was to transplant the two lobes into
different recipients after perfusion. In particular, technical adjustments would be required to optimize
bile and venous drainage. We present the split-liver technique as a model to optimize perfusion
protocols and evaluate interventions administered while on pump. For instance, there is great interest
in rehabilitating discarded livers for transplantation as a means of expanding the donor pool. In this
regard, the split-liver model has great potential as a powerful platform to evaluate any number of
therapeutic interventions.
Supplementary Materials: The following are available online at http://www.mdpi.com/2077-0383/9/1/269/s1,
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Lobar portal venous resistance was more variable during perfusion, demonstrating significant variance both
between and within livers, Figure S3: Individual split lobe ALT levels. Alanine transaminase (ALT) levels followed
similar patterns between lobes of the same liver during perfusion. Absolute ALT values varied significantly
between livers, reflective of the heterogeneity in discarded grafts obtained for research, Figure S4: Individual
split lobe lactate levels. Lactate levels followed similar patterns between lobes of the same liver. Most lobes
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